USPTO serial 87936116
OPENDOORS INDIVIDUALIZED CARE AND SUPPORT FOR PATIENTS LIKE YOU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2019
- Examiner
- WRIGHT, MARCO JABBAR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OPENDOORS INDIVIDUALIZED CARE AND SUPPORT FOR PATIENTS LIKE YOU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT, US
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT, US
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT, US
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott J. Major
SCOTT J. MAJOR MILLEN WHITE ZELANO & BRANIGAN, PC2200 CLARENDON BLVD., 14TH FLOORARLINGTON, VA 22201UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Providing information to idiopathic pulmonary fibrosis patients regarding insurance matters and payment options | SECTION 8 - CANCELLED | — |
| 041 | Educational services, namely, providing, classes, seminars and workshops regarding idiopathic pulmonary fibrosis, treatment of and caring for patients with idiopathic pulmonary fibrosis, and related insurance and payment issues | SECTION 8 - CANCELLED | — |
| 044 | Providing information on treatment for idiopathic pulmonary fibrosis and on coping with, caring for and understanding idiopathic pulmonary fibrosis | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named OPENDOORS INDIVIDUALIZED CARE AND SUPPORT FOR PATIENTS LIKE YOU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 17, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 17, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 13, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 9, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 9, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 29, 2019 | IUAF | USE AMENDMENT FILED | — |
| Oct 29, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 25, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 1, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 28, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 11, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 11, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 11, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 21, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 21, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |